Hydralazine and ATRA Target Breast Cancer Cells
A groundbreaking study has unveiled the promising therapeutic potential of combining hydralazine, a well-known antihypertensive agent, with all-trans retinoic acid ...
A groundbreaking study has unveiled the promising therapeutic potential of combining hydralazine, a well-known antihypertensive agent, with all-trans retinoic acid ...
In the relentless pursuit of novel cancer therapies, a groundbreaking discovery has emerged from the depths of the ocean, revealing ...
A groundbreaking study led by researchers at the University of Birmingham, in collaboration with the University of Turku in Finland, ...
Triple-negative breast cancer (TNBC) remains one of the most challenging subtypes of breast cancer to treat effectively. Defined by the ...
Recent research has shed light on a novel application of propofol, a well-known anesthetic, beyond its traditional use in surgery. ...
In the relentless fight against bladder cancer, a groundbreaking study published in Nature Communications unveils a transformative strategy that could ...
In a landmark development unveiled at the International Association for the Study of Lung Cancer 2025 World Conference on Lung ...
The landscape of cancer treatment is undergoing a profound transformation, driven in large part by the innovative integration of oncolytic ...
In a groundbreaking study, researchers have explored the potential of probiotic derivatives of Bacillus coagulans Hammer in facilitating apoptosis in ...
In a groundbreaking new study published in Medical Oncology, researchers have unveiled the potent protective effects of a pyrogallol-based nanocomposite ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine